Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge.
Severe fever with thrombocytopenia syndrome (SFTS) is a viral hemorrhagic fever caused by a tick-borne virus SFTSV with a mortality rate of up to 30%. Currently, there is no vaccine or effective therapy for SFTS. Neutralizing monoclonal antibody therapy, which provides immediate passive immunity and...
Saved in:
Main Authors: | Bang Li, Xiang-Rong Qin, Jia-Chen Qu, Guan-du Wu, Wen-Kang Zhang, Ze-Zheng Jiang, Pan-Pan Liu, Ze-Min Li, Tian-Mei Yu, Chuan-Min Zhou, Yong-Jun Jiao, Xue-Jie Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1012889 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a stable eukaryotic strain producing fully human monoclonal antibody on the basis of the human antibody against ectromelia virus
by: A. L. Matveev, et al.
Published: (2018-01-01) -
Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01) -
Role of Monoclonal Antibodies in the Treatment of Asthma
by: Paul M O’Byrne
Published: (2013-01-01) -
NSm is a critical determinant for bunyavirus transmission between vertebrate and mosquito hosts
by: Selim Terhzaz, et al.
Published: (2025-01-01) -
Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01)